The 6 references in paper Yu. Olefir V., A. Lutseva I., O. Vaganova A., A. Bendryshev A., T. Efremova A., Ю. Олефир В., А. Лутцева И., О. Ваганова А., А. Бендрышев А., Т. Ефремова А. (2018) “Подходы к определению высокомолекулярных агрегатов в глатирамоидах // Approaches to the definition of macromolecular aggregates in glatiramoids” / spz:neicon:vedomostincesmp:y:2015:i:4:p:16-19

1
Shvarts GYa, Ramenskaya GV. An analysis of the causes of the practical impossibility of creating generic Copaxone. Himiko-farmatsevticheskiy zhurnal
(check this in PDF content)
2
12; 46(11): 24–29 (in Russian). 2. Shvarts GYa, Ramenskaya GV. Some questions of circulation regulation of nonbiological medicinal products of complex chemical structure. Himikofarmatsevticheskiy zhurnal 2015; 49(4): 3–10 (in Russian).
(check this in PDF content)
3
Varkony H, Weinstein V, Klinger E, Sterling J, Cooperman H, Komlash T, Ladkani D, Schwartz R. The glatiramoid class of immunomodulator drugs. Expert Opinion Pharmacother. 2009; 10(4): 657–68.
(check this in PDF content)
4
Sigma Aldrich Catalog. Available from: http:// www.Simaaldrich.com\catalog\search\P1152.
(check this in PDF content)
5
Rosenberg AS. Effects of Protein Aggregates: An Immunologic Perspective. The AAPS Journal 2006; 8(3): 501–7.
(check this in PDF content)
6
Glatiramer Acetate Molecular Weight Markers. Patent WO/2012/016042. R E F E R E N C E S Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Health of the Russian Federation, 8 Petrovsky Boulevard, Moscow, 127051, Russian Federation.
(check this in PDF content)